Why the study?
Cardiovascular diseases are the leading cause of death worldwide and increase with age, but their impact on centenarians remains poorly understood.
Does cardiovascular disease incidence, severity, and survival differ between centenarians and non-centenarians?
Does cardiovascular disease incidence, severity, and survival differ between centenarians and non-centenarians?
Centenarians exhibit resilience to cardiovascular disease, characterized by delayed onset of severe conditions and better survival after diagnosis compared to the general population.
Answers are grounded in this paper and cite their sources.
Supports centenarian CVD resilience hypotheses; leaves open mechanisms and generalizability in this observational cohort.
Background: Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Although their prevalence increases with age, their impact on centenarians remains poorly understood. Methods: We analyzed Electronic Health Records (EHRs) to assess the incidence and effect of CVDs in centenarians (n = 649) and non-centenarians (n = 62,753) in the Basque Country. Descriptive statistics were applied to discern differences between the two population groups in terms of prevalence, number of diagnoses, and treatments. Survival analysis was performed through Kaplan-Meier estimator. Trajectories of laboratory parameters were explored through non-linear mixed models (NLMMs). Results: Centenarians had lower incidence of severe conditions such as ischemic heart disease, despite overall CVD incidence being similar between groups. Survival analyses revealed extended longevity in centenarians after both first and last CVD diagnosis. Biomarker trajectories suggested favorable biological profiles with greater resilience and faster recovery in centenarians. Conclusion: Despite experiencing CVDs, centenarians demonstrate delayed onset, reduced severity, and more favorable biological recovery compared to non-centenarians. These findings indicate potential resilience mechanisms that may contribute to healthy ageing.
No takes yet. Share an insight, caveat, or question.
Cruces-Salguero et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: